JPMorgan Chase & Co. Issues Pessimistic Forecast for Composecure (NYSE:GPGI) Stock Price

Composecure (NYSE:GPGIGet Free Report) had its price objective decreased by JPMorgan Chase & Co. from $22.00 to $15.00 in a research note issued to investors on Friday,Benzinga reports. The brokerage currently has a “neutral” rating on the stock. JPMorgan Chase & Co.‘s target price indicates a potential upside of 20.70% from the stock’s previous close.

Several other brokerages have also recently commented on GPGI. Weiss Ratings initiated coverage on Composecure in a research report on Monday, March 16th. They issued a “sell (d-)” rating for the company. Needham & Company LLC restated a “buy” rating on shares of Composecure in a report on Wednesday, March 25th. One research analyst has rated the stock with a Buy rating, one has given a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat.com, the company presently has an average rating of “Hold” and a consensus price target of $15.00.

Check Out Our Latest Stock Analysis on GPGI

Composecure Stock Up 0.1%

Shares of NYSE:GPGI traded up $0.01 during midday trading on Friday, reaching $12.43. The company’s stock had a trading volume of 495,091 shares, compared to its average volume of 3,778,798. Composecure has a 1 year low of $12.01 and a 1 year high of $26.78. The company has a market cap of $3.60 billion, a P/E ratio of -5.17 and a beta of 0.98.

Composecure (NYSE:GPGIGet Free Report) last issued its quarterly earnings results on Thursday, May 7th. The company reported $0.12 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.09 by $0.03. Composecure had a positive return on equity of 12.59% and a negative net margin of 56.76%.The company had revenue of $421.20 million for the quarter. During the same quarter last year, the business posted $0.25 earnings per share.

Insider Buying and Selling

In related news, Director Jane J. Thompson sold 13,667 shares of the firm’s stock in a transaction dated Tuesday, March 17th. The shares were sold at an average price of $16.91, for a total value of $231,108.97. Following the completion of the sale, the director directly owned 83,813 shares in the company, valued at approximately $1,417,277.83. This trade represents a 14.02% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, Director John D. Cote bought 5,800 shares of the business’s stock in a transaction that occurred on Tuesday, March 17th. The stock was purchased at an average price of $17.10 per share, with a total value of $99,180.00. Following the completion of the purchase, the director directly owned 5,800 shares in the company, valued at $99,180. The trade was a ? increase in their position. The disclosure for this purchase is available in the SEC filing. Insiders have purchased 56,725 shares of company stock worth $952,215 over the last three months. Company insiders own 18.40% of the company’s stock.

Composecure Company Profile

(Get Free Report)

CompoSecure, Inc manufactures and designs metal, plastic, composite ID, and proprietary financial transaction cards in the United States and internationally. Its primary metal form factors include embedded, metal veneer lite, metal veneer, and full metal products. The company also offers Arculus Cold Storage Wallet, a three-factor authentication solution, which comprise the Arculus Key card Cold Storage hardware device and companion Arculus Wallet mobile App to keep the Private Key in the Arculus Key card highly secure and store cryptocurrency and digital assets.

Further Reading

Receive News & Ratings for Composecure Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Composecure and related companies with MarketBeat.com's FREE daily email newsletter.